Pharma Journalist -

SMi Reports: Lynne Ensor the conference chair has invited fellow microbiologists to join her at upcoming SMi’s 3rd Annual Pharmaceutical Microbiology East Coast Conference. Lynne…
Read More...

Agenus Inc. announced that it has entered into an agreement with Betta Pharmaceuticals, a top Chinese pharmaceutical company focusing on the development of innovative oncology…
Read More...

Sarepta Therapeutics, Inc. and Codiak BioSciences, Inc. announced a global research and option agreement to design and develop engineered exosome therapeutics to deliver gene therapy,…
Read More...

Piramal Enterprises Limited's (PEL) Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), announced that the Company has entered into an…
Read More...

Ascentage Pharma announced a clinical collaboration with Acerta Pharma, the hematology research and development center of excellence of AstraZeneca. Under the terms of the…
Read More...

Merck, known as MSD outside the United States and Canada, announced the completion of the acquisition of Themis, a privately-held company focused on vaccines and immune-modulation…
Read More...

SMi reports: West Pharmaceutical Services to Host a Free Exclusive Webinar on Prefilled Syringe Elastomer Components High-Quality Solutions for Sensitive Molecules, taking place on 16th…
Read More...

Tonix Pharmaceuticals Holding Corp. announced an expansion of its strategic collaboration with Southern Research to include a study of T cell immune responses to SARS-CoV-2 in…
Read More...

Alpine Immune Sciences, Inc. and AbbVie Inc. announced an exclusive worldwide option and license agreement for ALPN-101, a first-in-class dual CD28/ICOS costimulation antagonist.…
Read More...

Sarepta Therapeutics and Selecta Biosciences, Inc. announced that they have entered into a Research License and Option agreement granting Sarepta an option to license the rights to…
Read More...